RESUMO
RATIONALE: Psoriasis is an immune-related disease caused by genetic factors, abnormalities in the immune system and environmental factors, while pemphigus is an autoimmune disease caused by the autoimmune system attacking the skin and mucosal tissues. Herein, we aimed to report a rare case of adalimumab induced exacerbation of psoriasis patients with pemphigus. The rare disease causes considerable challenges for clinical diagnosis and treatment. PATIENT CONCERNS: The patient was a 43-year-old man with intermittent erythema and scaling all over the body for more than 20 years, and blisters and vesicles on the trunk and limbs for 1 month. Half a year ago, the patient had blisters on the limbs, and was diagnosed with deciduous pemphigus in a hospital, and the blisters subsided after being given traditional Chinese medicine orally. Half a month ago, the erythema area was enlarged, and adalimumab 80 mg intramuscular injection was given for 1 time after consultation in the hospital. On the following day, the area of erythema and scales was suddenly enlarged obviously compared with the previous 1, and obvious blisters and vesicles appeared on the limbs, neck, and trunk, which were aggravated progressively and accompanied by obvious itching and pain. DIAGNOSES: The patient was diagnosed with psoriasis in patients with combined pemphigus. INTERVENTION: After combined treatment with methylprednisolone and cyclosporine, the skin lesions have basically recovered. OUTCOMES: The skin lesions have basically healed. Follow up for 6 months without recurrence. LESSONS: Methylprednisolone combined with cyclosporine may be an option in treating patients with psoriasis patients with pemphigus.
Assuntos
Pênfigo , Psoríase , Masculino , Humanos , Adulto , Pênfigo/tratamento farmacológico , Pênfigo/patologia , Adalimumab/efeitos adversos , Vesícula , Psoríase/complicações , Psoríase/tratamento farmacológico , Psoríase/patologia , Metilprednisolona/uso terapêutico , Eritema/patologia , Ciclosporina/uso terapêuticoRESUMO
Morbihan disease (MD) is considered a rare complication of rosacea, which is difficult to diagnose and challenging to treat. Here, we performed a systematic review of available case reports and case series to summarize key clinical and pathologic features of and successful treatment regimens for MD. We conducted a search of the PubMed/MEDLINE, EMBASE, and Cochrane electronic databases from their inception to the date of search on March 6, 2023. We found that MD affects patients in the fifth decade of life on average, more commonly reported in male than female (69% vs 31%). Clinically, MD affects the eyelids, cheeks, and forehead most commonly, presenting as non-pitting, erythematous edema or an edematous plaque. On biopsy, the pathologic features, such as dermal edema, sebaceous hyperplasia, perivascular and periadnexal inflammatory infiltrate, and granulomatous reaction, are frequently reported. Out of 55 patients who were able to achieve complete response without recurrence, 35% of patients were treated with isotretinoin and 22% were treated with tetracycline antibiotics with a daily dosage range of 20-80 mg and 40-200 mg, respectively. Out of those 55 patients, 22% and 7% were treated successfully with surgical intervention and intralesional injection of steroids, respectively. Additionally, lymphatic drainage has been shown to be an effective adjunctive therapeutic tool. More studies are necessary to understand the disease mechanism to improve the diagnosis of and develop evidence-based therapies for MD.
Assuntos
Rosácea , Humanos , Masculino , Feminino , Rosácea/diagnóstico , Eritema/patologia , Isotretinoína , Edema/patologia , Resultado do TratamentoAssuntos
Carcinoma Hepatocelular/metabolismo , Eritema/metabolismo , Hepatite C/metabolismo , Neoplasias Hepáticas/metabolismo , Zinco/deficiência , Idoso , Carcinoma Hepatocelular/etiologia , Quimioembolização Terapêutica , Suplementos Nutricionais , Eritema/tratamento farmacológico , Eritema/etiologia , Eritema/patologia , Feminino , Pé , Glucocorticoides/uso terapêutico , Hepacivirus , Hepatite C/complicações , Humanos , Perna (Membro) , Neoplasias Hepáticas/etiologia , Dermatopatias/tratamento farmacológico , Dermatopatias/etiologia , Dermatopatias/metabolismo , Dermatopatias/patologia , Zinco/uso terapêuticoRESUMO
OBJECTIVE: The aim of this study is to determine objective and subjective changes in mature hypertrophic burn scars treated with a fractional ablative carbon dioxide (CO2) laser. BACKGROUND: Fractional CO2 laser treatment has been reported to improve burn scars, with increasing clinical use despite a paucity of controlled, prospective clinical studies using objective measures of improvement. METHODS: A multicenter, site-controlled, prospective open-label study was conducted from 2013 to 2016. Objective and patient-reported outcome measures were documented at baseline, at each monthly laser treatment, and 6âmonths after treatment. Objective measurements employed were: mechanical skin torque to measure viscoelastic properties; ultrasonic imaging to measure scar thickness; and reflectometry to measure erythema and pigmentation. Subjective measures included health-related quality of life, patient and investigator scar assessment scales, and blinded scoring of before and after photographs. Subjects aged 11âyears or older with hypertrophic burn scars were recruited. Each subject received 3 monthly treatment sessions with an ablative fractionated CO2 laser. RESULTS: Twenty-nine subjects were enrolled, of whom 26 received at least 1 fractional CO2 laser treatment and 22 received 3 treatments. Mean age of those completing all 3 treatments was 28âyears. Statistically significant objective improvements in elastic stretch (P < 0.01), elastic recovery (P < 0.01), extensibility (P < 0.01), and thickness (P < 0.01) were noted. Patient- and physician-reported scar appearance and pain/pruritus were significantly improved (P < 0.01). There was no regression of improvement for at least 6âmonths after treatment. CONCLUSIONS: Fractional ablative laser treatment provides significant, sustained improvement of elasticity, thickness, appearance, and symptoms of mature hypertrophic burn scars.
Assuntos
Queimaduras/complicações , Cicatriz Hipertrófica/radioterapia , Lasers de Gás/uso terapêutico , Terapia com Luz de Baixa Intensidade , Adolescente , Adulto , Criança , Cicatriz Hipertrófica/diagnóstico por imagem , Cicatriz Hipertrófica/etiologia , Cicatriz Hipertrófica/patologia , Elasticidade , Eritema/patologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Qualidade de Vida , Pigmentação da Pele , Resultado do Tratamento , UltrassonografiaAssuntos
Acrodermatite/patologia , Eritema/patologia , Psoríase/dietoterapia , Psoríase/etiologia , Zinco/deficiência , Acrodermatite/diagnóstico , Acrodermatite/tratamento farmacológico , Acrodermatite/etiologia , Adolescente , Biópsia , Suplementos Nutricionais , Eritema/diagnóstico , Eritema/etiologia , Feminino , Pé/patologia , Humanos , Psoríase/diagnóstico , Psoríase/patologia , Resultado do Tratamento , Zinco/sangue , Zinco/uso terapêuticoRESUMO
BACKGROUND: Granuloma annulare (GA) is a skin disorder of uncertain etiology. Patch (type) GA is an uncommon variant of GA with a paucity of data characterizing it. We describe the features of 23 cases of patch GA. METHODS: The archives of dermatopathology were searched for cases of patch GA. The clinical history and morphology for each patient were reviewed. Only cases with patch clinical morphology were included. The clinical and histopathologic features were assessed including the pattern of granulomatous inflammation and presence of other inflammatory cell types. RESULTS: Most patients were female (19/23) with erythematous patches on the trunk and proximal extremities. The most common clinical differential diagnosis included mycosis fungoides (MF), morphea and contact dermatitis. Dyslipidemia was the most common comorbidity (30%), followed by diabetes (15%) and hypertension (15%). Histopathologic features included interstitial lymphocytes and histiocytes with dermal mucin. Two cases showed focal palisaded granulomas. Eosinophils and plasma cells were present in 1/3 of cases. CONCLUSION: Patch GA is an uncommon GA variant with an interstitial granulomatous histopathologic pattern that predominantly affects women over 50. It can mimic interstitial MF and early morphea both clinically and histopathologically. Awareness of this GA variant can help prevent misdiagnosis and inappropriate treatment for these patients.
Assuntos
Eritema/patologia , Extremidades/patologia , Granuloma Anular/patologia , Tronco/patologia , Corticosteroides/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Antimaláricos/uso terapêutico , Comorbidade , Dermatite de Contato/patologia , Diagnóstico Diferencial , Eosinófilos/patologia , Feminino , Granuloma Anular/diagnóstico , Granuloma Anular/terapia , Humanos , Inflamação/patologia , Masculino , Pessoa de Meia-Idade , Micose Fungoide/patologia , Fototerapia/métodos , Plasmócitos/patologia , Estudos Retrospectivos , Esclerodermia Localizada/patologiaRESUMO
INTRODUCTION: Capnocytophagacanimorsus (C. canimorsus), a commensal Gram-negative bacillus found in the oral cavity of dogs and cats, is pathogenic for humans, with the most common clinical manifestations being septicemia, meningitis and endocarditis. Herein we report a case of CC bacteremia manifesting as multiple plaques of erythema annulare centrifugum associated with monoarthritis of the knee. PATIENTS AND METHODS: A 66-year-old man consulted for a skin rash and monoarthritis of the right knee with fever following an insect bite on his right hallux. Cutaneous examination revealed numerous erythematous annular plaques on the trunk and limbs with centrifugal extension. Analysis of synovial fluid from the right knee showed an inflammatory liquid with a sterile bacteriological culture and PCR was negative for Borrelia. C. canimorsus bacteria were isolated from blood cultures. 16S RNA PCR performed on the synovial fluid was positive for the same organism. The patient's history revealed that his hallux wound had been licked by his dog. DISCUSSION: C. canimorsus most frequently affects immunosuppressed subjects. Cutaneous signs are seen in half of all cases, most frequently presenting as cellulitis, pathological livedo or thrombotic purpura. We report herein a case of CC bacteremia in an immunocompetent patient manifesting as multiple plaques of erythema annulare centrifugum, an unusual sign, and monoarthritis of one knee.
Assuntos
Artrite/microbiologia , Bacteriemia/complicações , Capnocytophaga , Eritema/microbiologia , Infecções por Bactérias Gram-Negativas/complicações , Articulação do Joelho , Dermatopatias Genéticas/microbiologia , Idoso , Animais , Doenças do Cão/microbiologia , Doenças do Cão/transmissão , Cães , Eritema/patologia , Humanos , Masculino , Dermatopatias Genéticas/patologiaAssuntos
Kava/efeitos adversos , Plantas Medicinais/efeitos adversos , Dermatopatias/patologia , Urticária/patologia , Doença Aguda , Assistência ao Convalescente , Anti-Inflamatórios/administração & dosagem , Anti-Inflamatórios/uso terapêutico , Biópsia , Diagnóstico Diferencial , Eritema/induzido quimicamente , Eritema/patologia , Exantema/induzido quimicamente , Exantema/patologia , Feminino , Humanos , Prednisolona/administração & dosagem , Prednisolona/uso terapêutico , Prurido/induzido quimicamente , Prurido/patologia , Dermatopatias/induzido quimicamente , Dermatopatias/diagnóstico , Dermatopatias/tratamento farmacológico , Síndrome de Resposta Inflamatória Sistêmica/induzido quimicamente , Síndrome de Resposta Inflamatória Sistêmica/tratamento farmacológico , Síndrome de Resposta Inflamatória Sistêmica/patologia , Resultado do Tratamento , Urticária/induzido quimicamente , Adulto JovemAssuntos
Calcinose/complicações , Eritema/etiologia , Pancreatite Crônica/complicações , Prurido/etiologia , Pele/patologia , Zinco/deficiência , Calcinose/diagnóstico , Suplementos Nutricionais , Eritema/tratamento farmacológico , Eritema/patologia , Feminino , Humanos , Pancreatite Crônica/diagnóstico , Prurido/tratamento farmacológico , Prurido/patologia , Pele/efeitos dos fármacos , Zinco/administração & dosagemRESUMO
Background and aim: The extract of ginger, obtained from the rhizome of Zingiber officinale, contains 6-gingerol, 6-shogaol, 8-gingerol, and 10-gingerol. It has many therapeutic effects such as being chemopreventive against stroke and heart diseases, malabsorption, bacterial infections, indigestion, and nausea, which have been observed since ancient times. The main aim of this study is to evaluate the polyurethane (PU) as a proper material for the hollow nanoparticles' preparation. Methods: The PU nanoparticles were obtained by a spontaneous emulsification, in the presence of a nonionic surfactant, combined with an interfacial polyaddition process between an aliphatic diisocyanate and different mixtures of etheric and esteric polyols. The synthesis was done without any PU additives, such as catalysts, blowing agents, chains promoters, cross-linking agents, and stabilizers. Results: The particles present almost neutral pH values and low water solubility. They are heat resistant up to 280°C. Decreased irritation level was found in the assay of PU nanoparticles loaded with pure ginger extract (GE) on the murine skin tests than the irritation level recorded for pure GE. Conclusion: This research shows the reduced noxiousness of these PU nanoparticles and consequently the possibility of their use as a possible cardiovascular protector.
Assuntos
Cardiotônicos/farmacologia , Nanopartículas/química , Extratos Vegetais/farmacologia , Poliuretanos/química , Zingiber officinale/química , Animais , Varredura Diferencial de Calorimetria , Eritema/patologia , Feminino , Concentração de Íons de Hidrogênio , Melaninas/metabolismo , Camundongos , Extratos Vegetais/química , Poliuretanos/síntese química , Solubilidade , Espectrofotometria Ultravioleta , TemperaturaRESUMO
OBJECTIVE: To observe the clinical effectiveness and safety of fire-needle therapy, an external approach of Chinese medicine in treating plaque psoriasis. METHODS: This study was a two-parallel-arm randomized controlled trial. A total of 151 participants with plaque psoriasis were randomly assigned to the fire-needle therapy group (treatment group, 76 cases) or the control group (75 cases) at a 1:1 allocation ratio using SAS software. All participants received Oral Huoxue Jiedu Decoction (, HXJDD) and applied externally vaseline cream twice a day. Participants in the treatment group received fire-needle therapy once weekly for 4 weeks plus HXJDD and vaseline cream applied the same as the control group. The primary outcome measure was Psoriasis Area and Severity Index (PASI) score, and the secondary outcomes were Dermatology Life Quality Index (DLQL), and Hamilton Anxiety Rating Scale (HAMA), as well as Chinese medicine (CM) syndrome score and photos of target lesions. The indices were evaluated before and after treatment. RESULTS: Sixty-eight patients in each group completed the study. The treatment group has not yet achieved significant improvement in PASI score (P>0.05) compared to the control group. However, significant differences were found between the two groups in relieving CM syndrome (P<0.05) and improving quality of life (P<0.05). CONCLUSION: Fire-needle appears to be safe and may have benefit for psoriasis, the short-term treatment and small sample size limit the conclusions of this study. Further rigorous randomized controlled trials with longer treatment are recommended.
Assuntos
Medicina Tradicional Chinesa , Psoríase/terapia , Adulto , Eritema/patologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Qualidade de Vida , Índice de Gravidade de DoençaRESUMO
A 34-year-old previously well woman presented with a 4-week history of diffuse erythema and crusting of skin affecting all four limbs. Examination revealed erythematous skin plaques associated with ulceration and fissuring affecting sun-exposed areas of all four limbs primarily on the dorsal surfaces, and a body mass index of 17 kg/m2 She was admitted under the infectious diseases unit, and an autoimmune and infective screen was performed which returned unremarkable. Dietetic consultation led to the diagnosis of severe protein-energy malnutrition, consequent to a severely restricted, primarily vegan, diet. Analysis of the patient's reported diet with nutritional software revealed grossly suboptimal caloric intake with risk of inadequacy for most micronutrients, vitamins and minerals, including niacin. Oral thiamine, multivitamin, iron supplementation and vitamin B complex were started, and a single intramuscular vitamin B12 dose was administered. Marked improvement was seen after 6 weeks, with near-complete resolution of skin changes. These findings supported a diagnosis of pellagra.
Assuntos
Micronutrientes/deficiência , Niacina/deficiência , Pelagra/diagnóstico , Pele/patologia , Dieta Vegana/efeitos adversos , Eritema/etiologia , Eritema/patologia , Feminino , Compostos Ferrosos/administração & dosagem , Compostos Ferrosos/uso terapêutico , Humanos , Hidroxocobalamina/administração & dosagem , Hidroxocobalamina/uso terapêutico , Pelagra/tratamento farmacológico , Pelagra/patologia , Tiamina/administração & dosagem , Tiamina/uso terapêutico , Resultado do Tratamento , Complexo Vitamínico B/administração & dosagem , Complexo Vitamínico B/uso terapêuticoRESUMO
No disponible
Assuntos
Humanos , Masculino , Adulto , Pênfigo Familiar Benigno/diagnóstico , Pênfigo Familiar Benigno/terapia , Fototerapia/métodos , Eritema/diagnóstico , Prednisona/administração & dosagem , Pescoço/patologia , Axila/patologia , Virilha/patologia , Extremidade Superior/patologia , Eritema/patologia , Mupirocina/administração & dosagem , Azóis/administração & dosagem , Fluconazol/administração & dosagem , Clotrimazol/administração & dosagem , Betametasona/administração & dosagemRESUMO
Skin is a major safeguard tissue in humans. Because biological barrier function is deteriorated by several kinds of stresses including exposure to ultra-violet (UV) rays, the protection and treatment of skin conditions by dietary supplements are important. We therefore evaluated the effects of dietary supplementation with an algal food-derived antioxidant, astaxanthin, on UV-induced skin deterioration. Twenty-three healthy Japanese participants were recruited to a 10-week double-blind placebo-controlled study. They were assigned to the astaxanthin group supplemented with a capsule containing 4 mg of astaxanthin or the placebo group. To assess the protective role of astaxanthin for UV-induced skin deterioration, we determined the minimal erythema dose (MED) and analyzed UV-induced changes of moisture and transepidermal water loss (TEWL) at baseline and after 9 weeks of supplementation. Subjective skin conditions were assessed by the visual analog scale. The astaxanthin group showed increased MED compared with placebo. In addition, the astaxanthin group had a reduced loss of skin moisture in the irradiated area compared with placebo. Subjective skin conditions for “improvement of rough skin” and “texture” in non-irradiated areas were significantly improved by astaxanthin. Astaxanthin seems protective against UV-induced skin deterioration and helps maintain healthy skin in healthy people.
Assuntos
Antioxidantes/administração & dosagem , Suplementos Nutricionais , Eritema/prevenção & controle , Envelhecimento da Pele/efeitos dos fármacos , Pele/efeitos dos fármacos , Queimadura Solar/prevenção & controle , Protetores Solares/administração & dosagem , Raios Ultravioleta/efeitos adversos , Administração Oral , Adulto , Antioxidantes/efeitos adversos , Cápsulas , Suplementos Nutricionais/efeitos adversos , Método Duplo-Cego , Eritema/etiologia , Eritema/patologia , Feminino , Voluntários Saudáveis , Humanos , Japão , Masculino , Pessoa de Meia-Idade , Pele/patologia , Pele/efeitos da radiação , Envelhecimento da Pele/efeitos da radiação , Queimadura Solar/etiologia , Queimadura Solar/patologia , Protetores Solares/efeitos adversos , Fatores de Tempo , Perda Insensível de Água/efeitos dos fármacos , Perda Insensível de Água/efeitos da radiação , Xantofilas/administração & dosagem , Xantofilas/efeitos adversosRESUMO
The negative effects triggered by ultraviolet radiation, such as premature aging and carcinogenesis, have motivated several studies on photoprotection. Recent strategies for photoprotection have included the incorporation of natural antioxidant and anti-inflammatory compounds, such as flavonoids, into sunscreens and the oral administration of natural antioxidant extracts. Brazilian Red propolis extract contains isoflavonoids with antioxidant and anti-inflammatory activities. Here, we investigate the photoprotective effects of orally- or topically-administered formulations containing hydroalcoholic extract of red propolis (HERP) in a rodent model. HERP showed markers identified as: daidzein (4.68⯵g/mL), formononetin (31.81⯵g/mL) and biochanin A (9.58⯵g/mL). A fourth peak was found in the chromatogram but was not identified. The antioxidant activity of HERP was calculated to be 3.07â¯mmolâ¯Trolox/g and 2.13â¯mmolâ¯Trolox/g, respectively. Topical HERP exerted a protective action against UVB radiation, which was similar to that exerted by oxybenzone filter. Oral HERP as an adjuvant treatment did not increase sunburn protection. However, the oral administration of HERP presented chemoprotective and anti-inflammatory activity (pâ¯<â¯0.05) similar or better than Polypodium leucotomos oral treatment (positive control). In conclusion, topical administration of HERP has photoprotective activity in a murine model and the mechanisms of protection can be related to the antioxidant and anti-inflammatory characteristics of HERP compounds.
Assuntos
Anti-Inflamatórios/química , Própole/química , Administração Tópica , Animais , Anti-Inflamatórios/farmacologia , Anti-Inflamatórios/uso terapêutico , Antioxidantes/metabolismo , Eritema/tratamento farmacológico , Eritema/patologia , Masculino , Extratos Vegetais/química , Ratos , Ratos Wistar , Pele/efeitos dos fármacos , Pele/patologia , Pele/efeitos da radiação , Raios UltravioletaRESUMO
BACKGROUND/PURPOSE: Sunburn and other health risks associated with excess sun exposure place huge economic burdens on societies, and create discomfort and disease within susceptible individuals. Oral supplements that reduce sunburn may be advantageous. This study evaluated the safety and efficacy of Bend Skincare Anti-Aging Formula to ameliorate sunburn induced with a solar simulator. METHODS: Subjects (n = 28) with Fitzpatrick skin phototypes I, II, or III took 4 capsules daily of the supplement providing 1400 mg of eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA), 120 mg of gamma-linolenic acid (GLA), 5 mg of lutein, 2.5 mg of zeaxanthin, and 1000 IU of vitamin D3 for 8 weeks. Skin on each subject's back was exposed to a progressive sequence of timed ultraviolet (UV) radiation exposure doses at baseline, and after 4- and 8-week treatment to determine their minimal erythema dose (MED). Results were compared before and after treatment using 3 paired t tests and subsequently 3 linear mixed models. RESULTS: Treatment significantly improved tolerance to UV exposure as evidenced by increased MED at 4 and 8 weeks compared with baseline (P < .001). This protection increased with prolonged use of Bend Skincare Anti-Aging Formula as demonstrated by progressively increased MED between baseline and 4 weeks, and again between 4 and 8 weeks (P < .001). Nearly 86% of patients responded to treatment within 4 weeks and 100% of patients responded by the end of the study, resulting in a 39% mean increase in MED at 4 weeks, and an 84% mean increase in MED at 8 weeks compared with baseline. Treatment was well tolerated with no product associated adverse events (AE) and only a few mild and expected side effects. CONCLUSION: Bend Skincare Anti-Aging Formula safely and effectively provides significant skin photoprotection that increases with continued use.
Assuntos
Colecalciferol/administração & dosagem , Eritema/prevenção & controle , Ácidos Graxos Ômega-3/administração & dosagem , Luteína/administração & dosagem , Envelhecimento da Pele/efeitos dos fármacos , Zeaxantinas/administração & dosagem , Adulto , Idoso , Eritema/patologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Tempo , Raios Ultravioleta/efeitos adversosRESUMO
PURPOSE: In the previous studies, positive effect of sunlight on seborrheic dermatitis may well be explained by the direct influence of UV-light on the yeasts. Narrow-band ultraviolet-B phototherapy appears to be a very effective and safe treatment option for patients with severe seborrheic dermatitis. We aimed to investigate the efficacy of narrow-band ultraviolet-B phototherapy as an alternative treatment for pityriasis versicolor. MATERIAL AND METHODS: A total of 38 patients diagnosed with disseminated pityriasis versicolor having more than four relapsing episodes within 12 months were treated with narrow-band ultraviolet-B phototherapy given three times weekly. Clinical assessment on the basis of the severity of pruritus, erythema/hyperpigmentation and scaling and mycological examination were made at Weeks 0, 4, 8, 12 and 16. RESULTS: Of the remaining 30 patients, 20 (66.7%) achieved excellent results and four patients (14%) had mild residual disease. The decrease in the clinical scores calculated at 4th week, 8th week, 12th week and 16th week were statistically significant. CONCLUSION: Narrow-band ultraviolet-B presumably may have an immunomodulatory and inhibitory effect on Malassezia growth. Narrowband ultraviolet-B is an effective and safe alternative tool for the management of extensive and recurrent pityriasis versicolor for patients who are unresponsive to conventional treatments.